Handelsbanken Fonder’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Sell |
30,200
-400
| -1% | -$6.93K | ﹤0.01% | 1226 |
|
|
2025
Q1 | $669K | Hold |
30,600
| – | – | ﹤0.01% | 1124 |
|
|
2024
Q4 | $976K | Buy |
30,600
+3,000
| +11% | +$95.7K | ﹤0.01% | 978 |
|
|
2024
Q3 | $796K | Buy |
27,600
+3,700
| +15% | +$107K | ﹤0.01% | 1037 |
|
|
2024
Q2 | $917K | Buy |
23,900
+1,500
| +7% | +$57.6K | ﹤0.01% | 876 |
|
|
2024
Q1 | $1.32M | Sell |
22,400
-200
| -0.9% | -$11.8K | 0.01% | 737 |
|
|
2023
Q4 | $1.35M | Buy |
22,600
+5,400
| +31% | +$323K | 0.01% | 684 |
|
|
2023
Q3 | $654K | Hold |
17,200
| – | – | ﹤0.01% | 923 |
|
|
2023
Q2 | $1.57M | Buy |
17,200
+2,200
| +15% | +$200K | 0.01% | 596 |
|
|
2023
Q1 | $989K | Buy |
15,000
+3,000
| +25% | +$198K | 0.01% | 696 |
|
|
2022
Q4 | $621K | Buy |
12,000
+300
| +3% | +$15.5K | ﹤0.01% | 843 |
|
|
2022
Q3 | $799K | Hold |
11,700
| – | – | 0.01% | 733 |
|
|
2022
Q2 | $529K | Sell |
11,700
-1,700
| -13% | -$76.9K | ﹤0.01% | 993 |
|
|
2022
Q1 | $681K | Hold |
13,400
| – | – | ﹤0.01% | 988 |
|
|
2021
Q4 | $634K | Hold |
13,400
| – | – | ﹤0.01% | 1187 |
|
|
2021
Q3 | $442K | Hold |
13,400
| – | – | ﹤0.01% | 1429 |
|
|
2021
Q2 | $847K | Buy |
13,400
+600
| +5% | +$37.9K | ﹤0.01% | 1017 |
|
|
2021
Q1 | $549K | Hold |
12,800
| – | – | ﹤0.01% | 1150 |
|
|
2020
Q4 | $732K | Hold |
12,800
| – | – | ﹤0.01% | 962 |
|
|
2020
Q3 | $386K | Hold |
12,800
| – | – | ﹤0.01% | 1124 |
|
|
2020
Q2 | $418K | Buy |
+12,800
| New | +$418K | ﹤0.01% | 1042 |
|